

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | PDHK (pyruvate dehydrogenase kinase) is a kinase enzyme which acts to inactivate the enzyme pyruvate dehydrogenase by phosphorylating it using ATP. AZD7545 is a novel PDHK inhibitor with IC50 values of 36.8nM/6.4nM for PDHK1/2[3], and EC50 value of 5.2nM for increasing PDH activity. It stimulated the rate of pyruvate oxidation with EC50 value of 105nM in rat hepatocytes. A single dose of AZD7545 to Wistar rats increased the proportion of liver PDH in its active, dephosphorylated form in a dose-related manner from 24.7 to 70.3% at 30 mg/kg; and in skeletal muscle from 21.1 to 53.3%. A single dose of 10 mg/kg also significantly elevated muscle PDH activity in obese Zucker (fa/fa) rats. AZD7545 (10 mg/kg) twice daily for 7 days markedly improved the 24-h glucose profile, by eliminating the postprandial elevation in blood glucose[4]. AZD7545 failed to inhibit PDHK4 and paradoxically, at higher concentrations (>10 nM), AZD7545 stimulated PDHK4 activity[3]. |
| 作用机制 | AZD7545 docks into the lipoamide-binding site on PDHK2 thus inhibiting interaction with the E2 subunit. It inhibits PDHK in a non-ATP competitive manner.[3] |
| Concentration | Treated Time | Description | References | |
| SKMel30 | 10 μM | 120 h | Inhibition of PDK1 leads to growth suppression of NRAS mutant cells | Mol Cancer. 2017 Jun 8;16(1):102. |
| 501Mel | 10 μM | 90 h | Inhibition of PDK1 leads to growth suppression of BRAFV600E mutant cells | Mol Cancer. 2017 Jun 8;16(1):102. |
| IGR37 | 10 μM | 90 h | Inhibition of PDK1 leads to growth suppression of BRAFV600E mutant cells | Mol Cancer. 2017 Jun 8;16(1):102. |
| A375 | 10 μM | 90 h | Inhibition of PDK1 leads to growth suppression of BRAFV600E mutant cells | Mol Cancer. 2017 Jun 8;16(1):102. |
| PDK3 | 50 nM | 30 min | Determination of IC50 for AZD7545 on PDK3, resulting in 600 nM | Structure. 2007 Aug;15(8):992-1004. |
| PDK1 | 50 nM | 30 min | Determination of IC50 for AZD7545 on PDK1, resulting in 87 nM | Structure. 2007 Aug;15(8):992-1004. |
| MelJuso | 10 μM | 120 h | Inhibition of PDK1 leads to growth suppression of NRAS mutant cells | Mol Cancer. 2017 Jun 8;16(1):102. |
| IPC298 | 10 μM | 120 h | Inhibition of PDK1 leads to growth suppression of NRAS mutant cells | Mol Cancer. 2017 Jun 8;16(1):102. |
| SK-MEL-2 | >100 μM | 96 h | AZD7545 did not significantly inhibit proliferation in SK-MEL-2 cells, IC50 >100 μM | Int J Mol Sci. 2022 Mar 29;23(7):3745. |
| SK-MEL-28 | >100 μM | 96 h | AZD7545 did not significantly inhibit proliferation in SK-MEL-28 cells, IC50 >100 μM | Int J Mol Sci. 2022 Mar 29;23(7):3745. |
| MeWo | 89.3 ±5.0 μM | 96 h | AZD7545 inhibited proliferation in MeWo cells with an IC50 of 89.3 ±5.0 μM | Int J Mol Sci. 2022 Mar 29;23(7):3745. |
| A375 | 35.0 ±4.1 μM | 96 h | AZD7545 inhibited proliferation in A375 cells with an IC50 of 35.0 ±4.1 μM | Int J Mol Sci. 2022 Mar 29;23(7):3745. |
| Dose | Rat: 10 mg/kg - 30 mg/kg[2] (p.o.), 300 mg/kg[3] (p.o.) |
| Administration | p.o. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.09mL 0.42mL 0.21mL |
10.44mL 2.09mL 1.04mL |
20.88mL 4.18mL 2.09mL |
|
| CAS号 | 252017-04-2 |
| 分子式 | C19H18ClF3N2O5S |
| 分子量 | 478.87 |
| SMILES Code | O=C(N(C)C)C1=CC=C(S(=O)(C2=CC=C(NC([C@@](C)(O)C(F)(F)F)=O)C(Cl)=C2)=O)C=C1 |
| MDL No. | MFCD25976792 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | DTDZLJHKVNTQGZ-GOSISDBHSA-N |
| Pubchem ID | 16741245 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 45 mg/mL(93.97 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1